Simone P Pinheiro

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women
    Simone P Pinheiro
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
    Cancer Res 66:5521-5. 2006
  2. ncbi Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies
    Simone P Pinheiro
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer Epidemiol Biomarkers Prev 19:1595-601. 2010
  3. ncbi Mumps and ovarian cancer: modern interpretation of an historic association
    Daniel W Cramer
    Department of Obstetrics and Gynecology Epidemiology Center, Obstetrics and Gynecology Epidemiology Center, Brigham and Women s Hospital BWH, Harvard Medical School, 221 Longwood Ave, RFB 366, Boston, MA 02115, USA
    Cancer Causes Control 21:1193-201. 2010
  4. ncbi Racial differences in premenopausal endogenous hormones
    Simone P Pinheiro
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 14:2147-53. 2005
  5. ncbi Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts
    Simone P Pinheiro
    Department of Medicine, Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Epidemiol 169:1378-87. 2009
  6. ncbi Non-genomic biomarkers of risk in ovarian cancer
    Simone P Pinheiro
    Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Dis Markers 23:355-66. 2007

Detail Information

Publications6

  1. ncbi A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women
    Simone P Pinheiro
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
    Cancer Res 66:5521-5. 2006
    ..05). In this prospective study, we found no convincing evidence for an association between sleep duration and the incidence of breast cancer...
  2. ncbi Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies
    Simone P Pinheiro
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer Epidemiol Biomarkers Prev 19:1595-601. 2010
    ..Antibodies developed against tumor-like MUC1 in response to such events could be one way through which ovarian cancer risk factors operate...
  3. ncbi Mumps and ovarian cancer: modern interpretation of an historic association
    Daniel W Cramer
    Department of Obstetrics and Gynecology Epidemiology Center, Obstetrics and Gynecology Epidemiology Center, Brigham and Women s Hospital BWH, Harvard Medical School, 221 Longwood Ave, RFB 366, Boston, MA 02115, USA
    Cancer Causes Control 21:1193-201. 2010
    ..To explain this association, we investigated whether mumps might engender immunity to ovarian cancer through antibodies against the cancer-associated antigen MUC1 abnormally expressed in the inflamed parotid gland...
  4. ncbi Racial differences in premenopausal endogenous hormones
    Simone P Pinheiro
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 14:2147-53. 2005
    ..Further research is needed to explore differences across racial groups and the link between endogenous hormones and breast cancer risk...
  5. ncbi Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts
    Simone P Pinheiro
    Department of Medicine, Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Epidemiol 169:1378-87. 2009
    ..In this large prospective study, the authors found no compelling evidence to support an association between regular use of aspirin, nonaspirin NSAIDs, or acetaminophen and ovarian cancer incidence...
  6. ncbi Non-genomic biomarkers of risk in ovarian cancer
    Simone P Pinheiro
    Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Dis Markers 23:355-66. 2007